Variant report
Variant | nsv1026043 |
---|---|
Chromosome Location | chr9:1079462-1732502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2935)
- CpG islands (count:0)
- Chromatin interactive region (count:100)
- LncRNA region (count:43)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr9:1262535-1262860 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr9:1232418-1233152 | HepG2 | liver: | n/a | n/a |
3 | ARID3A | chr9:1165172-1165199 | HepG2 | liver: | n/a | n/a |
4 | ARID3A | chr9:1454262-1454586 | HepG2 | liver: | n/a | n/a |
5 | ATF2 | chr9:1469886-1470491 | GM12878 | blood: | n/a | n/a |
6 | ATF2 | chr9:1536421-1536930 | GM12878 | blood: | n/a | n/a |
7 | ATF2 | chr9:1267069-1267434 | GM12878 | blood: | n/a | n/a |
8 | ATF2 | chr9:1490362-1491115 | GM12878 | blood: | n/a | n/a |
9 | ATF2 | chr9:1273849-1274227 | GM12878 | blood: | n/a | n/a |
10 | ATF2 | chr9:1490307-1491149 | GM12878 | blood: | n/a | n/a |
11 | ATF2 | chr9:1267004-1267465 | GM12878 | blood: | n/a | n/a |
12 | ATF2 | chr9:1469879-1470564 | GM12878 | blood: | n/a | n/a |
13 | ATF2 | chr9:1536424-1536957 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr9:1273755-1274200 | GM12878 | blood: | n/a | chr9:1274007-1274018 |
15 | BATF | chr9:1490384-1491050 | GM12878 | blood: | n/a | n/a |
16 | BATF | chr9:1232670-1232943 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr9:1468627-1468906 | GM12878 | blood: | n/a | n/a |
18 | BATF | chr9:1522204-1522433 | GM12878 | blood: | n/a | n/a |
19 | BATF | chr9:1536479-1536843 | GM12878 | blood: | n/a | chr9:1536673-1536683 |
20 | BATF | chr9:1536433-1537132 | GM12878 | blood: | n/a | chr9:1536673-1536683 |
21 | BATF | chr9:1470009-1470366 | GM12878 | blood: | n/a | chr9:1470172-1470183 chr9:1470265-1470278 |
22 | BATF | chr9:1267065-1267439 | GM12878 | blood: | n/a | n/a |
23 | BATF | chr9:1505545-1505846 | GM12878 | blood: | n/a | n/a |
24 | BATF | chr9:1490300-1491164 | GM12878 | blood: | n/a | n/a |
25 | BATF | chr9:1522199-1522450 | GM12878 | blood: | n/a | n/a |
26 | BATF | chr9:1514759-1515190 | GM12878 | blood: | n/a | chr9:1514963-1514974 |
27 | BATF | chr9:1267089-1267384 | GM12878 | blood: | n/a | n/a |
28 | BATF | chr9:1666546-1666849 | GM12878 | blood: | n/a | chr9:1666712-1666723 |
29 | BATF | chr9:1311457-1311704 | GM12878 | blood: | n/a | n/a |
30 | BATF | chr9:1535619-1535903 | GM12878 | blood: | n/a | n/a |
31 | BCL11A | chr9:1271872-1272106 | GM12878 | blood: | n/a | n/a |
32 | BCL11A | chr9:1536584-1536781 | GM12878 | blood: | n/a | chr9:1536675-1536684 |
33 | BCL11A | chr9:1490707-1491032 | GM12878 | blood: | n/a | n/a |
34 | BCL11A | chr9:1267058-1267389 | GM12878 | blood: | n/a | n/a |
35 | BCL11A | chr9:1522157-1522444 | GM12878 | blood: | n/a | n/a |
36 | BCL11A | chr9:1490371-1491127 | GM12878 | blood: | n/a | n/a |
37 | BCL11A | chr9:1536449-1536835 | GM12878 | blood: | n/a | chr9:1536675-1536684 |
38 | BCL11A | chr9:1273798-1274241 | GM12878 | blood: | n/a | n/a |
39 | BCL11A | chr9:1522572-1522804 | GM12878 | blood: | n/a | n/a |
40 | BCL11A | chr9:1554412-1554724 | GM12878 | blood: | n/a | n/a |
41 | BCL11A | chr9:1273784-1274155 | GM12878 | blood: | n/a | n/a |
42 | BCL11A | chr9:1267051-1267422 | GM12878 | blood: | n/a | n/a |
43 | BCL3 | chr9:1458432-1458804 | GM12878 | blood: | n/a | chr9:1458740-1458749 chr9:1458739-1458748 |
44 | BCL3 | chr9:1469934-1470495 | GM12878 | blood: | n/a | n/a |
45 | BCL3 | chr9:1458553-1458815 | GM12878 | blood: | n/a | chr9:1458740-1458749 chr9:1458739-1458748 |
46 | BCL3 | chr9:1536446-1536852 | GM12878 | blood: | n/a | chr9:1536675-1536684 |
47 | BCLAF1 | chr9:1604933-1605323 | GM12878 | blood: | n/a | n/a |
48 | BCLAF1 | chr9:1267023-1267355 | GM12878 | blood: | n/a | n/a |
49 | BCLAF1 | chr9:1490297-1491172 | GM12878 | blood: | n/a | n/a |
50 | BCLAF1 | chr9:1490418-1491093 | GM12878 | blood: | n/a | n/a |
No data |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:1721060..1723569-chr9:1724371..1726152,2 | MCF-7 | breast: | |
2 | chr9:1050050..1050882-chr9:1198084..1198894,4 | MCF-7 | breast: | |
3 | chr9:1453549..1456481-chr9:1457480..1459717,2 | K562 | blood: | |
4 | chr9:1329896..1332390-chr9:1334019..1336447,2 | MCF-7 | breast: | |
5 | chr9:1459777..1461278-chr9:1604683..1605512,7 | MCF-7 | breast: | |
6 | chr9:1459729..1460626-chr9:1605062..1605562,2 | MCF-7 | breast: | |
7 | chr9:1315772..1318545-chr9:1320375..1322632,2 | K562 | blood: | |
8 | chr9:1049884..1051008-chr9:1336243..1337579,9 | MCF-7 | breast: | |
9 | chr9:1100620..1101481-chr9:1337009..1337893,4 | MCF-7 | breast: | |
10 | chr9:1463195..1465097-chr9:1468058..1470697,2 | MCF-7 | breast: | |
11 | chr9:1454281..1457237-chr9:1457484..1459959,2 | MCF-7 | breast: | |
12 | chr9:1414222..1417184-chr9:1419869..1422079,2 | K562 | blood: | |
13 | chr9:1459863..1460538-chr9:1837555..1838175,2 | MCF-7 | breast: | |
14 | chr9:1100898..1101474-chr9:1619645..1620185,2 | MCF-7 | breast: | |
15 | chr9:1017784..1019327-chr9:1158625..1160475,2 | MCF-7 | breast: | |
16 | chr9:1492000..1494748-chr9:1498884..1501267,2 | MCF-7 | breast: | |
17 | chr9:1459862..1460804-chr9:1527712..1529112,4 | MCF-7 | breast: | |
18 | chr9:1050736..1051474-chr9:1211377..1212172,7 | MCF-7 | breast: | |
19 | chr9:1163342..1166297-chr9:1170947..1173135,2 | MCF-7 | breast: | |
20 | chr9:1050169..1051008-chr9:1198034..1198952,5 | MCF-7 | breast: | |
21 | chr9:1474110..1476318-chr9:1485269..1488138,2 | MCF-7 | breast: | |
22 | chr9:1100633..1101579-chr9:1428962..1429946,8 | MCF-7 | breast: | |
23 | chr9:1048582..1050101-chr9:1206689..1209470,2 | MCF-7 | breast: | |
24 | chr9:1167206..1169983-chr9:1171593..1173584,2 | MCF-7 | breast: | |
25 | chr9:1197110..1199229-chr9:1201325..1204281,3 | MCF-7 | breast: | |
26 | chr9:1605194..1607051-chr9:1607421..1609783,2 | MCF-7 | breast: | |
27 | chr9:1120059..1122097-chr9:1123938..1125710,2 | K562 | blood: | |
28 | chr9:1604812..1606126-chr9:1619456..1620358,3 | MCF-7 | breast: | |
29 | chr9:1172064..1174566-chr9:1177825..1179718,2 | MCF-7 | breast: | |
30 | chr9:1048644..1051362-chr9:1182528..1184402,2 | MCF-7 | breast: | |
31 | chr9:1124326..1126756-chr9:1130042..1131544,2 | MCF-7 | breast: | |
32 | chr9:1199075..1201039-chr9:1246978..1249972,2 | K562 | blood: | |
33 | chr17:35897413..35898334-chr9:1234312..1235126,2 | MCF-7 | breast: | |
34 | chr9:1444036..1446024-chr9:1452969..1455867,2 | MCF-7 | breast: | |
35 | chr9:1100638..1101499-chr9:1337048..1337780,3 | MCF-7 | breast: | |
36 | chr9:1453549..1456481-chr9:1457480..1459717,2 | K562 | blood: | |
37 | chr9:1459729..1460626-chr9:1605062..1605562,2 | MCF-7 | breast: | |
38 | chr9:1474110..1476318-chr9:1485269..1488138,2 | MCF-7 | breast: | |
39 | chr9:1172064..1174566-chr9:1177825..1179718,2 | MCF-7 | breast: | |
40 | chr9:1329896..1332390-chr9:1334019..1336447,2 | MCF-7 | breast: | |
41 | chr9:1050302..1051381-chr9:1211162..1212085,6 | MCF-7 | breast: | |
42 | chr9:1050100..1050940-chr9:1085686..1086526,2 | MCF-7 | breast: | |
43 | chr9:1605194..1607051-chr9:1607421..1609783,2 | MCF-7 | breast: | |
44 | chr9:1709062..1709904-chr9:1836847..1837727,2 | MCF-7 | breast: | |
45 | chr9:1207734..1210015-chr9:1211203..1213257,2 | MCF-7 | breast: | |
46 | chr9:1197110..1199229-chr9:1201325..1204281,3 | MCF-7 | breast: | |
47 | chr9:1721060..1723569-chr9:1724371..1726152,2 | MCF-7 | breast: | |
48 | chr9:1049307..1051830-chr9:1209993..1212929,2 | MCF-7 | breast: | |
49 | chr9:1048591..1051547-chr9:1195558..1198367,2 | MCF-7 | breast: | |
50 | chr9:1156903..1158809-chr9:1163538..1165114,2 | MCF-7 | breast: |
(count:43 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SMARCA2-2 | chr9:1633518-1633545 | XLOC_007264 |
2 | lnc-DMRT2-2 | chr9:1327074-1327173 | XLOC_007263 |
3 | lnc-DMRT2-2 | chr9:1310940-1311032 | XLOC_007263 |
4 | lnc-DMRT2-2 | chr9:1299313-1299412 | NONHSAT129967 |
5 | lnc-DMRT2-4 | chr9:1288277-1288431 | l_3725_chr9:1288276-1302899_breast |
6 | lnc-DMRT2-2 | chr9:1327074-1327173 | XLOC_007263 |
7 | lnc-DMRT2-2 | chr9:1310940-1311032 | XLOC_007263 |
8 | lnc-DMRT2-4 | chr9:1318425-1318584 | l_3725_chr9:1288276-1302899_breast |
9 | lnc-DMRT2-5 | chr9:1328664-1328987 | NONHSAT129974 |
10 | lnc-DMRT2-2 | chr9:1310940-1311032 | XLOC_007263 |
11 | lnc-DMRT2-2 | chr9:1321457-1321494 | XLOC_007263 |
12 | lnc-DMRT2-2 | chr9:1299314-1299412 | XLOC_007263 |
13 | lnc-DMRT2-2 | chr9:1298286-1298431 | XLOC_007263 |
14 | lnc-DMRT2-2 | chr9:1327073-1327173 | NONHSAT129967 |
15 | lnc-DMRT2-6 | chr9:1368147-1368400 | NONHSAT129976 |
16 | lnc-DMRT2-2 | chr9:1321457-1321494 | XLOC_007263 |
17 | lnc-DMRT2-2 | chr9:1310940-1311032 | XLOC_007263 |
18 | lnc-DMRT2-2 | chr9:1312841-1312897 | XLOC_007263 |
19 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
20 | lnc-DMRT2-2 | chr9:1299314-1299412 | XLOC_007263 |
21 | lnc-DMRT2-4 | chr9:1289314-1289412 | l_3725_chr9:1288276-1302899_breast |
22 | lnc-DMRT2-2 | chr9:1328424-1328584 | NONHSAT129967 |
23 | lnc-C9orf66-13 | chr9:1164414-1164867 | NONHSAT129966 |
24 | lnc-DMRT2-6 | chr9:1354235-1354272 | NONHSAT129976 |
25 | lnc-DMRT2-2 | chr9:1312841-1312899 | XLOC_007263 |
26 | lnc-DMRT2-2 | chr9:1328425-1328584 | XLOC_007263 |
27 | lnc-DMRT2-4 | chr9:1300940-1301032 | l_3725_chr9:1288276-1302899_breast |
28 | lnc-DMRT2-2 | chr9:1310940-1311032 | XLOC_007263 |
29 | lnc-DMRT2-4 | chr9:1302841-1302899 | l_3725_chr9:1288276-1302899_breast |
30 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
31 | lnc-DMRT2-2 | chr9:1312840-1312899 | NONHSAT129967 |
32 | lnc-DMRT2-2 | chr9:1298276-1298431 | NONHSAT129967 |
33 | lnc-DMRT2-2 | chr9:1310940-1311032 | XLOC_007263 |
34 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
35 | lnc-C9orf66-12 | chr9:1151807-1152140 | NONHSAT129965 |
36 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
37 | lnc-SMARCA2-2 | chr9:1718867-1718912 | XLOC_007264 |
38 | lnc-DMRT2-2 | chr9:1299314-1299412 | XLOC_007263 |
39 | lnc-DMRT2-4 | chr9:1317074-1317173 | l_3725_chr9:1288276-1302899_breast |
40 | lnc-DMRT2-2 | chr9:1310939-1311032 | NONHSAT129967 |
41 | lnc-DMRT2-2 | chr9:1328425-1328435 | XLOC_007263 |
42 | lnc-DMRT2-2 | chr9:1321456-1321494 | NONHSAT129967 |
43 | lnc-DMRT2-2 | chr9:1298277-1298431 | XLOC_007263 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000233575 | TF binding region |
ENSG00000224836 | TF binding region |
RPS27AP14 | TF binding region |
RNA5SP279 | TF binding region |
ENSG00000221227 | chromatin interactions |
ENSG00000236594 | chromatin interactions |
ENSG00000173253 | chromatin interactions |
ENSG00000006114 | chromatin interactions |
AP2M1 | miRNA target sites |
AP3D1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530883287 | chr9:1082600-1082601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550686979 | chr9:1082602-1082603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537267498 | chr9:1082610-1082611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79972878 | chr9:1082637-1082638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs58569219 | chr9:1082661-1082662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551106492 | chr9:1082663-1082664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535095160 | chr9:1082705-1082706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368977764 | chr9:1082712-1082713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10156621 | chr9:1082727-1082728 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs375984938 | chr9:1082765-1082766 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs534109301 | chr9:1082771-1082772 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs572232024 | chr9:1082778-1082779 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs541287272 | chr9:1082813-1082814 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs556820839 | chr9:1082833-1082834 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs187013189 | chr9:1082849-1082850 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs576770955 | chr9:1082945-1082946 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs376538117 | chr9:1082957-1082958 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs545437300 | chr9:1082997-1082998 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs559313275 | chr9:1082999-1083000 | Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs191452668 | chr9:1083044-1083045 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs369325839 | chr9:1083109-1083110 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs564396693 | chr9:1083117-1083118 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs577867851 | chr9:1083125-1083126 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs539745940 | chr9:1083128-1083129 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs150598719 | chr9:1083155-1083156 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs7024033 | chr9:1083171-1083172 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs10959261 | chr9:1083173-1083174 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs10959262 | chr9:1083199-1083200 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs563766155 | chr9:1083262-1083263 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs77320772 | chr9:1083300-1083301 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs115373124 | chr9:1083309-1083310 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs546636603 | chr9:1083330-1083331 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs566887562 | chr9:1083335-1083336 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs529432785 | chr9:1083349-1083350 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs10959263 | chr9:1083372-1083373 | Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs549733228 | chr9:1083417-1083418 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs375231554 | chr9:1083421-1083422 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs59445668 | chr9:1083422-1083423 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs569465972 | chr9:1083435-1083436 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs201050930 | chr9:1083444-1083445 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs13299202 | chr9:1083445-1083446 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs559729019 | chr9:1083455-1083456 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs558335950 | chr9:1083474-1083475 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs372715113 | chr9:1083484-1083485 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs576825536 | chr9:1083556-1083557 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs528490137 | chr9:1083564-1083565 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs71327373 | chr9:1083565-1083566 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs398087088 | chr9:1083572-1083573 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs398096235 | chr9:1083573-1083574 | Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs143216744 | chr9:1083728-1083729 | Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 21272361 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Breast cancer | 22522925 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1082600-1082800 | Enhancers | NHDF-Ad | bronchial |
2 | chr9:1082800-1083000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr9:1082800-1084000 | Active TSS | NHDF-Ad | bronchial |
4 | chr9:1083000-1083200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr9:1083000-1083200 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr9:1083000-1083400 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr9:1083000-1083400 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr9:1083000-1083800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr9:1083000-1084000 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr9:1083000-1084200 | Active TSS | Brain Cingulate Gyrus | brain |
11 | chr9:1083200-1083400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr9:1083200-1083600 | Active TSS | Fetal Muscle Trunk | muscle |
13 | chr9:1083200-1083800 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
14 | chr9:1083200-1083800 | Active TSS | Cortex derived primary cultured neurospheres | brain |
15 | chr9:1083200-1083800 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
16 | chr9:1083200-1083800 | Active TSS | Adipose Nuclei | Adipose |
17 | chr9:1083200-1083800 | Active TSS | Brain Hippocampus Middle | brain |
18 | chr9:1083200-1083800 | Active TSS | Brain Inferior Temporal Lobe | brain |
19 | chr9:1083200-1083800 | Active TSS | HSMM | muscle |
20 | chr9:1083200-1084000 | Bivalent Enhancer | Breast Myoepithelial Primary Cells | Breast |
21 | chr9:1083200-1084000 | Active TSS | Brain Anterior Caudate | brain |
22 | chr9:1083200-1084000 | Active TSS | Psoas Muscle | Psoas |
23 | chr9:1083400-1083600 | Bivalent/Poised TSS | HUES64 Cell Line | embryonic stem cell |
24 | chr9:1083400-1083600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
25 | chr9:1083400-1083600 | Bivalent/Poised TSS | Brain Germinal Matrix | brain |
26 | chr9:1083400-1083800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
27 | chr9:1083400-1083800 | Active TSS | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
28 | chr9:1083400-1083800 | Bivalent/Poised TSS | HUES6 Cell Line | embryonic stem cell |
29 | chr9:1083400-1083800 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
30 | chr9:1083400-1083800 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
31 | chr9:1083400-1083800 | Active TSS | Muscle Satellite Cultured Cells | -- |
32 | chr9:1083400-1083800 | Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
33 | chr9:1083400-1083800 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
34 | chr9:1083400-1083800 | Active TSS | Brain Dorsolateral Prefrontal Cortex | brain |
35 | chr9:1083400-1083800 | Active TSS | Brain Substantia Nigra | brain |
36 | chr9:1083400-1083800 | Active TSS | Colon Smooth Muscle | Colon |
37 | chr9:1083400-1083800 | Active TSS | Duodenum Smooth Muscle | Duodenum |
38 | chr9:1083400-1083800 | Active TSS | Fetal Brain Female | brain |
39 | chr9:1083400-1083800 | Bivalent/Poised TSS | Fetal Lung | lung |
40 | chr9:1083400-1083800 | Active TSS | Fetal Muscle Leg | muscle |
41 | chr9:1083400-1083800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
42 | chr9:1083400-1083800 | Active TSS | Right Atrium | heart |
43 | chr9:1083400-1083800 | Active TSS | Skeletal Muscle Male | skeletal muscle |
44 | chr9:1083400-1083800 | Active TSS | HSMMtube | muscle |
45 | chr9:1083400-1084000 | Bivalent/Poised TSS | HUES48 Cell Line | embryonic stem cell |
46 | chr9:1083400-1084000 | Bivalent/Poised TSS | iPS-18 Cell Line | embryonic stem cell |
47 | chr9:1083400-1084000 | Bivalent/Poised TSS | iPS-20b Cell Line | embryonic stem cell |
48 | chr9:1083400-1084000 | Active TSS | Brain Angular Gyrus | brain |
49 | chr9:1083400-1084000 | Active TSS | Skeletal Muscle Female | skeletal muscle |
50 | chr9:1083400-1084000 | Active TSS | A549 | lung |